 Research Triangle Park, N.C. October 12, 2010. Novella Clinical Inc. announced today that it has appointed Charles R. Lambert to the position of Chief Financial Officer, where he will be responsible for overseeing all aspects of Novella Clinical’s financial operations. He will also work closely with the executive management team to develop opportunities to continue the strong growth trajectory of the company.
Prior to joining Novella Clinical, Mr. Lambert spent 12 years in the healthcare IT sector, most recently as Chief Financial Officer of Capario, a healthcare technology company focused on revenue cycle management. Prior to Capario, Mr. Lambert served as the Chief Financial Officer of Misys Healthcare Systems, a software company focused on the Hospital and Ambulatory Healthcare IT markets. During his 30 year career, Mr. Lambert has worked in a range of industries and lived and worked both in Europe and Asia, as well as the USA. He has held executive-level positions at public and privately-held companies in the healthcare, technology and industrial sectors, and also acted in several General Manager positions during his tenure at Misys. He graduated from Cambridge University in the United Kingdom and is a qualified Chartered Accountant.
“We are pleased to have Charles’ deep expertise in running global businesses and his experience in the healthcare sector. His expertise will be critical as we continue to expand into new global markets, as well as contributing to our mergers and acquisitions activities,” commented Richard Staub, President and CEO.
“I am delighted to be joining the Novella Clinical team. The business has experienced impressive growth over the last few years and has deep clinical expertise. It is well regarded in the industry and is well positioned going forward. I look forward to working with the rest of the management team to realize the full potential of the business,” added Mr. Lambert.
About Novella Clinical
For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although our clinical experience is all-inclusive, our eClinical roots enable us to offer services that are specific to our clients’ needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report — we integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. Our focus on quality customer service is reflected in our certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008). For more information, visit www.novellaclinical.com.
### |